BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 27, 2003
View Archived Issues
Unnatural, Outlandish Antibody Sets Stage For Long-Sought Vaccine To Outsmart Deadly HIV
Read More
Axonyx Starting Phase III Study Of Phenserine For Alzheimer's
Read More
Advisory Panel Recommends Against Serono's Serostim
Read More
Other News To Note
Read More
Nektar Prices $100M In Notes As It Moves Programs Forward
Drug delivery firm Nektar Therapeutics priced its offering of $100 million in notes reported earlier this week.
Read More
MethylGene, Merck Enter Deal On Drugs For Antibiotic Resistance
Read More